Skip to main content
. 2022 Aug 23;239(1):72–80. doi: 10.1159/000525987

Fig. 1.

Fig. 1

Cases of NS treated with ixekizu­mab. a Patient 1 after 6 weeks of treatment with ixekizumab. b Improved skin condition after 1 year of treatment. c Widespread polycyclic, double-edged scaling and erythematous plaques before treatment with ixekizumab in patient 2. d Substantial improvement after 2 years and 4 months of treatment.